市場調查報告書
商品編碼
1411021
CHC(消費者醫療保健)創新:2024Innovation in CHC 2024 |
全球消費者保健市場每年推出數千種創新產品,但為消費者帶來顯著新益處的劑型或配方相對較少。
2023 年,美容護理、益生菌和益生元以及護髮/美容補充劑的推出迅速增加,推動了 NPD 活動。在後新冠疫情情勢下,以化妝品為重點的品類是上市活動的主要動力,此外還有性健康和生育產品、鎮靜劑和助眠劑。展望未來,我們看到各種 Rx-to-OTC 轉換候選者和創新趨勢可能會在未來幾年推動 CHC 市場的成長,包括個人化醫療、抗衰老補充劑等的使用增加預防產品指出。
本報告詳細審視了 2023 年的消費者醫療保健 (CHC),重點介紹了消費者醫療保健行業最引人注目的交付形式和成分趨勢。我們依地區、國家和主要市場研究新產品趨勢,以探索 CHC 創新的未來。
Thousands of innovations are launched every year in the global consumer healthcare market, but relatively few offer notable new benefits for consumers in terms of delivery format or formulation. Which new products are breaking through and offering a unique proposition? Where will new product development take the CHC market in future?
The latest title from CHC New Products Tracker takes an in-depth look at 100 key CHC innovations in 2023, and picks out some of the most prominent delivery format and ingredient trends in the consumer healthcare industry. It examines new product activity by region, country and leading marketer, and explores what the future might hold in terms of CHC innovation.
Showcasing the best CHC innovation of the past year, including:
Highlighting 5 major delivery format trends in the CHC market, including:
Highlighting 10 major ingredient, flavour and labelling trends in the CHC market, including:
|
|
In 2023, NPD activity was driven by a surge in launches of aesthetic (beauty) treatments, probiotics & prebiotics and hair & beauty supplements. In the post-Covid landscape, cosmetic-focused categories have been an important driver of launch activity, along with sexual health & fertility products and sedatives & sleep aids. Looking to the future, we pinpoint various Rx-to-OTC switch candidates and innovation trends that will unlock CHC market growth over the coming years, including greater use of personalized medicine, anti-ageing supplements and prevention products more generally.